Skip to content

Author

Yang Zi

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jan 2026

Integrative Multiomics Analysis Reveals a Cancer Stem Cell–Driven Prognostic Signature and Nominates Belinostat for Targeted Therapy in Hepatocellular Carcinoma

This study establishes a novel CSC–associated gene signature for diagnosis and prognosis in HCC and nominates belinostat as a repurposing candidate for targeting stemness‐related pathways, offering a promising strategy for personalized therapy.

Yang Zi, Ying Zhang, Jun Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.